63 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
1 Feb 24
Material Change Report
11:50am
of the F8 formulation by the FDA because the Company’s responses are not to the satisfaction of the FDA. We refer current and potential investors
6-K
EX-99.1
THTX
Theratechnologies Inc.
24 Jan 24
Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA
1:52pm
responses are not to the satisfaction of the FDA. We refer current and potential investors to the “Risk Factors” section of our Annual Information
F-3
THTX
Theratechnologies Inc.
21 Dec 23
Shelf registration (foreign)
1:21pm
the holders to receive Common Shares or other Securities or combination of Securities upon the satisfaction of certain conditions, typically the completion … of the subscription proceeds for the Subscription Receipts are held in escrow by the Escrow Agent, pending the satisfaction of the conditions. Holders
6-K
EX-99.5
a8soois2
3 Nov 23
First Amendment to Credit Agreement
2:26pm
6-K
EX-99.6
70fmhmp on5
3 Nov 23
First Amendment to Credit Agreement
2:26pm
6-K
EX-99.4
ynddnj0vscg3asj60
3 Nov 23
First Amendment to Credit Agreement
2:26pm
6-K
EX-99.1
8t7hol5k mkh393l3md
3 Nov 23
First Amendment to Credit Agreement
2:26pm
6-K
EX-99.1
2khtd4x1fuqp9yg4
26 Oct 23
Current report (foreign)
9:15pm
SUPPL
wchkkro63ylv 63a0zm
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
nqpu8mkinzkjt9
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
ibtj7n9
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.1
swbuw cm1klr
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
cyut3oii
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
3ta1mmny11gn7 z7x
25 Sep 23
Material Change Report
3:32pm
6-K
EX-99.1
5oq3m26xl0xy1 5m
25 Sep 23
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
11:40am
6-K
EX-99.2
4lmn2
21 Jul 22
Material Change Report
4:40pm
6-K/A
EX-99.1
sp9qyi8xfp3nhi78
20 Jul 22
Theratechnologies Announces Binding Commitment for a
3:13pm
6-K
EX-99.2
71nxm
14 Jul 22
Interim Consolidated Financial Statements
8:00am